cytarabine
Ligand Summary
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
UNII: 04079A1RDZ
PubChem: 6253
ChEMBL: CHEMBL803
DrugCentral: 770
LyCHI: AGMYQ3854DM7
Target Activities
5 Activities
Items per page:
10
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
INHIBITOR | ||||||
INHIBITOR | ||||||
INHIBITOR | ||||||
IC50 | ||||||